Fluorescence Imaging of Bacterial Killing by Antimicrobial Peptide Dendrimer G3KL.
暂无分享,去创建一个
[1] T. Lu,et al. Peptide Design Principles for Antimicrobial Applications. , 2019, Journal of molecular biology.
[2] J. Reymond,et al. Peptide dendrimers G3KL and TNS18 inhibit Pseudomonas aeruginosa biofilms , 2019, Applied Microbiology and Biotechnology.
[3] J. Reymond,et al. Antimicrobial Peptide Dendrimer Chimera , 2019, Helvetica Chimica Acta.
[4] J. Vederas,et al. The expanding structural variety among bacteriocins from Gram-positive bacteria. , 2018, FEMS microbiology reviews.
[5] J. Reymond,et al. Optimizing Antimicrobial Peptide Dendrimers in Chemical Space. , 2018, Angewandte Chemie.
[6] Jean-Louis Reymond,et al. Lipidated Peptide Dendrimers Killing Multidrug-Resistant Bacteria. , 2018, Journal of the American Chemical Society.
[7] J. L. T. Tjeerdsma-van Bokhoven,et al. Imaging the antimicrobial mechanism(s) of cathelicidin-2 , 2016, Scientific Reports.
[8] G. Qiao,et al. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers , 2016, Nature Microbiology.
[9] N. Malanovic,et al. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides. , 2016, Biochimica et biophysica acta.
[10] L. Hamoen,et al. Analysis of Antimicrobial-Triggered Membrane Depolarization Using Voltage Sensitive Dyes , 2016, Front. Cell Dev. Biol..
[11] Dominique P. Pioletti,et al. Anti-Microbial Dendrimers against Multidrug-Resistant P. aeruginosa Enhance the Angiogenic Effect of Biological Burn-wound Bandages , 2016, Scientific Reports.
[12] L. Otvos,et al. Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane. , 2015, Chemistry & biology.
[13] H. Jenssen,et al. Peptides and Peptidomimetics for Antimicrobial Drug Design , 2015, Pharmaceuticals.
[14] J. Reymond,et al. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa. , 2014, Angewandte Chemie.
[15] Yoonkyung Park,et al. How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23. , 2014, ACS chemical biology.
[16] H. Mukundan,et al. Lipopolysaccharide-induced dynamic lipid membrane reorganization: tubules, perforations, and stacks. , 2014, Biophysical journal.
[17] Jesmin Akter,et al. Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria , 2014, Bioconjugate chemistry.
[18] Q. Ma,et al. Antimicrobial Properties and Membrane-Active Mechanism of a Potential α-Helical Antimicrobial Derived from Cathelicidin PMAP-36 , 2014, PloS one.
[19] J. Reymond,et al. Expanding the topological space of bioactive peptides. , 2014, Chimia.
[20] Y. Negishi,et al. Maleylated-BSA induces TNF-α production through the ERK and NF-κB signaling pathways in murine RAW264.7 macrophages , 2013 .
[21] J. Reymond,et al. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP. , 2013, Organic & biomolecular chemistry.
[22] J. Shaevitz,et al. Fast, Multiphase Volume Adaptation to Hyperosmotic Shock by Escherichia coli , 2012, PloS one.
[23] J. Reymond,et al. Peptide and glycopeptide dendrimer apple trees as enzyme models and for biomedical applications. , 2012, Organic & biomolecular chemistry.
[24] A. Kozlov,et al. SSB-DNA binding monitored by fluorescence intensity and anisotropy. , 2012, Methods in molecular biology.
[25] Marco M. Domingues,et al. Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems. , 2012, Biopolymers.
[26] H. Vogel,et al. The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.
[27] R. Bucki,et al. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37 , 2011, Proceedings of the National Academy of Sciences.
[28] E S Bishop,et al. Characterization of PicoGreen interaction with dsDNA and the origin of its fluorescence enhancement upon binding. , 2010, Biophysical journal.
[29] Jian Li,et al. Structure--activity relationships of polymyxin antibiotics. , 2010, Journal of medicinal chemistry.
[30] G. J. Gabriel,et al. Stimuli-Responsive Polyguanidino-Oxanorbornene Membrane Transporters as Multicomponent Sensors in Complex Matrices , 2008, Journal of the American Chemical Society.
[31] S. Opal. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. , 2007, International journal of medical microbiology : IJMM.
[32] Joanna Trylska,et al. Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies. , 2006, Journal of medicinal chemistry.
[33] W. Shafer,et al. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages , 2005, Cellular microbiology.
[34] Z. Wasylewski,et al. Fluorescence quenching and kinetic studies of conformational changes induced by DNA and cAMP binding to cAMP receptor protein from Escherichia coli , 2005, The FEBS journal.
[35] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[36] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[37] T. Tani,et al. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. , 2001, The Journal of surgical research.
[38] T. Mattila-Sandholm,et al. Fluorometric assessment of Gram‐negative bacterial permeabilization , 2000, Journal of applied microbiology.
[39] Itzhak Fishov,et al. Visualization of membrane domains in Escherichia coli , 1999, Molecular microbiology.
[40] H. Nikaido,et al. Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.
[41] R. Lindemann. Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide , 1988, Infection and immunity.